LCS
APLM icon

Levin Capital Strategies’s Apollomics APLM Stock Holding History

Levin Capital Strategies’s Portfolio APLM Stock Details APLM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-110
Closed -$61.8K – 274
2023
Q2 		$61.8K Buy
+110
New +$63.7K 0.01% 255

Other funds holding APLM

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Levin Capital Strategies's APLM Position: Q3 2023 in Review

Levin Capital Strategies sold out of Apollomics (APLM) in Q3 2023, closing a stake of 110 shares — an estimated $61.8K sold.

Levin Capital Strategies first reported a position in APLM in Q2 2023 and held it in 1 quarter. The position peaked at $61.8K in Q2 2023. 10 funds tracked by Wall St. Rank hold APLM as of Q3 2023.

  • Levin Capital Strategies reported no remaining Apollomics position as of Q3 2023 after selling out during the quarter.
  • Levin Capital Strategies sold 110 Apollomics shares in Q3 2023, an estimated $61.8K.
  • Levin Capital Strategies first reported a position in Apollomics in Q2 2023 and held it in 1 quarter.
  • Levin Capital Strategies's Apollomics position peaked at $61.8K in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Apollomics as of Q3 2023.

Based on Levin Capital Strategies's 13F filing for Q3 2023, filed 31 Oct 2023.